RecruitingPhase 4NCT06715280
Switching of Sildenafil to Riociguat in CTEPH Patients
Studying Chronic thromboembolic pulmonary hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chinese University of Hong Kong
- Intervention
- Riociguat (Adempas)(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Prince of Wales Hospital, Hong Kong, Hong Kong
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06715280 on ClinicalTrials.govOther trials for Chronic thromboembolic pulmonary hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07522203Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary AngioplastyIstanbul Mehmet Akif Ersoy Educational and Training Hospital
- RECRUITINGNCT07272798Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary HypertensionDamascus University
- RECRUITINGNCT07299227Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow HaemodynamicsKerckhoff Klinik
- RECRUITINGNCT07217522Rutgers University Study of the Genetics of Pulmonary HypertensionRutgers, The State University of New Jersey
- RECRUITINGNCT07254078Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTensionIrina E. Chazova
- RECRUITINGPHASE3NCT06922240Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)Suqiao Yang
- RECRUITINGPHASE3NCT05140525Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPHDr Sudarshan Rajagopal
- RECRUITINGNCT06081881Chronic Thromboembolic Pulmonary Hypertension After Pulmonary EmbolismEster Ashraf Faried Beshay
See all trials for Chronic thromboembolic pulmonary hypertension →